Drugs in MeSH Category Adrenergic alpha-1 Receptor Antagonists

« Back to Dashboard

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dava Pharms Inc	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	076161-001	Jun 10, 2004	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Nesher Pharms	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	075609-004	Oct 18, 2000		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Innogenix	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	075215-003	Jul 29, 1999	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.